Why the study?
Can a clinical risk model accurately predict diabetic cardiovascular autonomic neuropathy in Chinese diabetic patients?
Can a clinical risk model accurately predict diabetic cardiovascular autonomic neuropathy in Chinese diabetic patients?
A newly developed clinical risk model using routine clinical variables demonstrated high sensitivity and specificity for predicting diabetic cardiovascular autonomic neuropathy in a Chinese population.
May aid diabetic CAN prediction in Chinese patients; leaves open external validation before clinical adoption.
Background: We developed clinical risk models for predicting diabetic cardiovascular autonomic neuropathy (DCAN) in Chinese diabetic patients. Methods: A Chinese cohort of 455 diabetic participants underwent a short heart rate variability (HRV) test which was recruited between 2011 and 2013. Clinical risk models were developed that included independent and significant risk factors by using multiple variable stepwise regressions. These clinical risk models were tested in another independent cohort of Chinese individuals. Results: The clinical risk models included age, fasting plasma glucose, 2-h plasma blood glucose, triglycerides, resting HRs, and duration of diabetes mellitus. The area under the receiver-operating characteristic (ROC) curve of the study group was 0.794. In the model with the continuous variables, the area under the ROC curve was 0.810. A cutoff score of 12.54 which produced the optimal sensitivity (68.20%) and specificity (76.80%) and identified the percentage (35.77%) of the population that required subsequent testing. Conclusions: The clinical risk models showed high sensitivity and specificity for the prediction of DCAN in Chinese diabetic patients.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: